Morepen Laboratories Q1 Results
- BSE: 500288
- NSE: MOREPENLAB
- ISIN: INE083A01026
- Sector: Biotechnology & Drugs
BSE
38.47
-1.82 (-4.52%)
-1.82 (-4.52%)Volume2.22 L
Updated: Fri 13 Mar, 2026 | 15:29:57
NSE
38.11-2.15 (-5.34%)
-2.15 (-5.34%)Volume3.48 M
Updated: Fri 13 Mar, 2026 | 15:46:53
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Quarter ended Jun 25
Note: Comparison is on QoQ basis
Quarterly - Morepen Laboratories Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 25 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 410.09 | 440.08 | -6.81% | 409.32 | 0.19% |
| Depreciation/ Amortization | 9.03 | 16.47 | -45.20% | 5.73 | 57.57% |
| Operating Income | 15.15 | 25.77 | -41.24% | 45.89 | -67.00% |
| Net Income | 10.75 | 20.32 | -47.09% | 36.17 | -70.28% |
| Other Operating Expenses Total | 36.32 | 26.30 | 38.13% | 28.54 | 27.28% |
| Net Income Before Taxes | 15.52 | 25.71 | -39.66% | 48.17 | -67.79% |
| Total Revenue | 425.24 | 465.85 | -8.72% | 455.22 | -6.59% |
| Selling/ General/ Admin Expenses Total | 91.82 | 69.50 | 32.13% | 82.98 | 10.66% |
| Diluted Normalized EPS | 0.20 | 0.36 | -45.20% | 0.71 | -71.83% |